C.129P2(B6)-Krt10tm1Tmm/H

Status

Available to order

EMMA IDEM:02463
International strain nameC.129P2(B6)-Krt10tm1Tmm/H
Alternative nameK10T+/-
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolKrt10tm1Tmm
Gene/Transgene symbolKrt10

Information from provider

ProviderRebecca Porter
Provider affiliationCardiff University
Additional ownerProf. Thomas Magin, Institute of Physiological Chemistry, Bonn, Germany
Genetic informationThe targeting vector was constructed from a 129P2/OlaHsd mouse genomic library and designed to replace exons 3-7 of the K10 gene by the mouse HPRT minigene (Porter et al., 1996). The hypoxanthin-phosphoribosyl-transferase (HPRT) minigene was flanked by sequences homologous to the K10 locus (short arm homology: 1.2 kb, long arm of homology: 2.7 kb) and an HSV-TK (herpes simplex virus thymidine kinase) cassette. The construct was cloned into a Bluescript II SK+ vector (Stratagene) and electroporated into HM-1 ES cells.
Phenotypic informationK10T mice show a phenotype in the epidermis and in tongue, esophagus and forestomach. Homozygous pups die on the first day after birth from dehydration due to generalised blistering within the epidermis. Heterozygous mice look normal at birth and develop a progressive thickening of the skin and hyperkeratosis. Their skin is scaly. Heterozygotes breed normally.
References
  • Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.;Porter R M, Leitgeb S, Melton D W, Swensson O, Eady R A, Magin T M, ;1996;The Journal of cell biology;132;925-36; 8603923
  • Out of balance: consequences of a partial keratin 10 knockout.;Reichelt J, Bauer C, Porter R, Lane E, Magin V, ;1997;Journal of cell science;0;2175-86; 9378767
  • The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.;Porter R M, Reichelt J, Lunny D P, Magin T M, Lane E B, ;1998;The Journal of investigative dermatology;110;951-7; 9620304
  • Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis.;Reichelt J, Doering T, Schnetz E, Fartasch M, Sandhoff K, Magin A M, ;1999;The Journal of investigative dermatology;113;329-34; 10469329

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

MGI allele-associated human disease models

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • scaly ears / MGI
  • abnormal autopod morphology / MGI
  • abnormal foot pad morphology / MGI
  • reddish skin / MGI
  • scaly skin / MGI
  • flaky skin / MGI
  • abnormal epidermis suprabasal layer morphology / MGI
  • abnormal epidermis stratum spinosum morphology / MGI
  • abnormal epidermis stratum granulosum morphology / MGI
  • hyperkeratosis / MGI
  • decreased body weight / MGI
  • abnormal skin morphology / MGI
  • abnormal tail morphology / MGI
  • increased susceptibility to infection / MGI
  • translucent skin / MGI
  • blistering / MGI
  • abnormal epidermis stratum basale morphology / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • acanthosis / MGI
  • decreased skin tensile strength / MGI
  • neonatal lethality, complete penetrance / MGI
MGI phenotypes (gene matching)
  • scaly ears / MGI
  • ruffled hair / MGI
  • abnormal autopod morphology / MGI
  • abnormal foot pad morphology / MGI
  • enlarged sebaceous gland / MGI
  • reddish skin / MGI
  • scaly skin / MGI
  • flaky skin / MGI
  • translucent skin / MGI
  • blistering / MGI
  • abnormal epidermal layer morphology / MGI
  • epidermal hyperplasia / MGI
  • abnormal epidermis stratum basale morphology / MGI
  • abnormal epidermis suprabasal layer morphology / MGI
  • abnormal epidermis stratum spinosum morphology / MGI
  • abnormal epidermis stratum granulosum morphology / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • hyperkeratosis / MGI
  • decreased body weight / MGI
  • acanthosis / MGI
  • decreased incidence of induced tumors / MGI
  • abnormal skin morphology / MGI
  • abnormal tail morphology / MGI
  • increased susceptibility to infection / MGI
  • abnormal sebaceous lipid secretion / MGI
  • decreased skin tensile strength / MGI
  • greasy coat / MGI
  • abnormal stratum corneum lipid matrix formation / MGI
  • hypergranulosis / MGI
  • increased keratohyalin granule size / MGI
  • neonatal lethality, complete penetrance / MGI
  • increased sebum secretion / MGI
  • abnormal sebocyte morphology / MGI
  • abnormal sebocyte differentiation / MGI
  • increased sebocyte proliferation / MGI

Literature references

  • Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.;Porter R M, Leitgeb S, Melton D W, Swensson O, Eady R A, Magin T M, ;1996;The Journal of cell biology;132;925-36; 8603923
  • Out of balance: consequences of a partial keratin 10 knockout.;Reichelt J, Bauer C, Porter R, Lane E, Magin V, ;1997;Journal of cell science;0;2175-86; 9378767
  • The relationship between hyperproliferation and epidermal thickening in a mouse model for BCIE.;Porter R M, Reichelt J, Lunny D P, Magin T M, Lane E B, ;1998;The Journal of investigative dermatology;110;951-7; 9620304
  • Normal ultrastructure, but altered stratum corneum lipid and protein composition in a mouse model for epidermolytic hyperkeratosis.;Reichelt J, Doering T, Schnetz E, Fartasch M, Sandhoff K, Magin A M, ;1999;The Journal of investigative dermatology;113;329-34; 10469329

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).